Enhancement of anti-tumor effect of antibody-drug conjugate in combination with nobiletin and other PMFs

被引：0
|
作者：
Masuoka, Tomoya [1 ]
Iwasawa, Takumi [1 ]
Yonezawa, Takayuki [2 ]
Watanabe, Akio [3 ]
Woo, Jetae [2 ]
Kato, Kazunori [1 ]
机构：
[1] Toyo Univ, Grad Sch Sci Eng, Tokyo, Japan
[2] Chubu Univ, Grad Sch Biotech, Kasugai, Aichi, Japan
[3] Jumonji Univ, Niiza, Saitama, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-1046
引用
收藏
页码：393 / 393
页数：1
相关论文
共 50 条
  • [21] A first-in-class anti-TROP2/EGFR bispecific antibody-drug conjugate, DM001, exhibits potent anti-tumor efficacy
    Li, Zhuolin
    Shang, Chengzhang
    Guan, Xuewa
    An, Gao
    Guo, Yuming
    Zhang, Ellen
    Lin, Qingcong
    Yang, Yi
    CANCER RESEARCH, 2023, 83 (08)
  • [22] Identification of BAY 94-9343, a mesothelin antibody-drug conjugate (ADC): Characterization and anti-tumor activity in mesothelin-positive preclinical tumor models
    Golfier, Sven
    Kahnert, Antje
    Heisler, King
    Kopitz, Charlotte
    Berhoerster, Kerstin
    Stelte-Ludwig, Beatrix
    Mayer-Bartschmid, Anke
    Bruder, Sandra
    Linden, Lars
    Harrenga, Axel
    Schatz, Christoph
    Kreft, Bertolt
    Mueller-Tiemann, Beate
    Ziegelbauer, Karl
    CANCER RESEARCH, 2011, 71
  • [23] Overcoming Resistance to Anti-Nectin-4 Antibody-Drug Conjugate
    Cabaud, Olivier
    Berger, Ludovic
    Crompot, Emerence
    Adelaide, Jose
    Finetti, Pascal
    Garnier, Severine
    Guille, Arnaud
    Carbuccia, Nadine
    Farina, Anne
    Agavnian, Emilie
    Chaffanet, Max
    Goncalves, Anthony
    Charafe-Jauffret, Emmanuelle
    Mamessier, Emilie
    Birnbaum, Daniel
    Bertucci, Francois
    Lopez, Marc
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (07) : 1227 - 1235
  • [24] Brentuximab vedotin: An anti-CD30 antibody-drug conjugate
    Bradley, Amber M.
    Devine, Meghan
    DeRemer, David
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (07) : 589 - 597
  • [25] Enhancement of the anti-tumor effect of combination with human tumor necrosis factor-alpha
    Fujiwara, Yuki
    Ohashi, Toya
    Haruki, Koichiro
    Furukawa, Kenei
    Shimada, Yohta
    Iida, Tomonori
    Shiba, Hiroaki
    Uwagawa, Tadashi
    Kobayashi, Hiroshi
    Misawa, Takeyuki
    Yanaga, Katsuhiko
    JOURNAL OF GENE MEDICINE, 2014, 16 (7-8): : 223 - 224
  • [26] Quantitative Evaluation of the Effect of Antigen Expression Level on Antibody-Drug Conjugate Exposure in Solid Tumor
    Bussing, David
    Sharma, Sharad
    Li, Zhe
    Meyer, Lyndsey F.
    Shah, Dhaval K.
    AAPS JOURNAL, 2021, 23 (03):
  • [27] Effect of PEG chain length on antibody-drug conjugate tumor and tissue distribution in tumor bearing xenograft mice
    Chemuturi, Nagendra V.
    Anderson, Martha
    Cochran, Julia
    Pires, Thomas
    Hunter, Josh
    Meyer, David
    Neale, Jason
    Chin, Alice
    Pittman, Paul
    Balasubramanian, Cindy
    Zapata, Francisco
    Simmons, Jessica
    Lyon, Robert
    Alley, Steve
    CANCER RESEARCH, 2017, 77
  • [28] Synergistic enhancement of cancer therapy using a combination of carbon nanotubes and anti-tumor drug
    Mahmood, Meena
    Karmakar, Alokita
    Fejleh, Ashley
    Mocan, Teodora
    Iancu, Cornel
    Mocan, Lucian
    Iancu, Dana Todea
    Xu, Yang
    Dervishi, Enkeleda
    Li, Zhongrui
    Biris, Alexandru R.
    Agarwal, Rakhee
    Ali, Nawab
    Galanzha, Ekaterina I.
    Biris, Alexandru S.
    Zharov, Vladimir P.
    NANOMEDICINE, 2009, 4 (08) : 883 - 893
  • [29] BCG022, a novel HER3 x MET bispecific antibody-drug conjugate (bsADC), demonstrates promising anti-tumor efficacy
    Li, Zhuolin
    Shang, Chengzhang
    Han, Zhenyan
    An, Gao
    Guo, Chaoshe
    An, W. Frank
    Yang, Yi
    CANCER RESEARCH, 2024, 84 (06)
  • [30] A novel topoisomerase I inhibitor antibody-drug conjugate targeting CEACAM5 has potent anti-tumor activity in colorectal cancer models
    Baudat, Yves
    Neff-LaFord, Haley
    Nicolazzi, Celine
    Meyer, Dave
    Sigurjonsson, Johann Petur
    Lyski, Ryan
    Fantin, Valeria
    Brun, Marie-Priscille
    Chiron, Marielle
    Decary, Stephanie
    CANCER RESEARCH, 2023, 83 (07)
12345